An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Vortioxetine

Encapsulated vortioxetine immediate-release tablets

DRUG

Placebo

Vortioxetine placebo-matching capsules

Trial Locations (33)

Unknown

Anaheim

Arcadia

Irvine

National City

Sherman Oaks

Upland

Washington D.C.

Bradenton

Coral Gables

North Miami

St. Petersburg

Tampa

Oak Brook

Park Ridge

Lafayette

Wichita

Baltimore

Fall River

Worcester

Flowood

Brooklyn

New York

The Bronx

Morganton

Cincinnati

Toledo

Oklahoma City

Portland

Lincoln

Memphis

Austin

San Antonio

Charleston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Takeda

INDUSTRY